Market Cap 1.25B
Revenue (ttm) 348.97M
Net Income (ttm) 5.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1.68%
Debt to Equity Ratio -6.28
Volume 4,600,500
Avg Vol 4,945,086
Day's Range N/A - N/A
Shares Out 321.54M
Stochastic %K 85%
Beta 1.12
Analysts Strong Sell
Price Target $7.97

Company Profile

MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provi...

Industry: Biotechnology
Sector: Healthcare
Phone: 818 661 5000
Address:
1 Casper Street, Danbury, United States
Kuka
Kuka Aug. 19 at 12:46 PM
$MNKD the Algos repeat ... yesterday we had just a .06 penny swing so today I've got a limit order set for $3.96.
0 · Reply
riback9
riback9 Aug. 19 at 12:22 PM
0 · Reply
Solicurance
Solicurance Aug. 19 at 11:13 AM
$MNKD wonder when we get fast track designation for 201…
2 · Reply
clan
clan Aug. 19 at 10:40 AM
$MNKD Blockbuster potential. For the good of all Mannkind. 🇺🇲 $SPY 💪 $QQQ 🇺🇲
0 · Reply
oloccip__evets
oloccip__evets Aug. 19 at 9:29 AM
0 · Reply
ChristineMartinez757
ChristineMartinez757 Aug. 19 at 9:15 AM
$MNKD $WDC $NBIZ $USO MannKind develops inhaled and specialty medicines, Western Digital benefits from storage demand, NBIZ remains highly speculative, and USO provides crude-oil exposure. I'm watching prescription growth, data-storage cycles, funding, oil prices, and energy-market conditions.
0 · Reply
jiw392
jiw392 Aug. 19 at 9:09 AM
0 · Reply
Kuka
Kuka Aug. 19 at 3:52 AM
$MNKD just my humble opinion but I am guessing we are going to blow LQDA stock price out of the water ... this might take a year or two.
1 · Reply
kevinmik
kevinmik Aug. 19 at 2:20 AM
$MNKD Real world data showing Technophere DPI is safely used in a complex disease like diabetes opens the door wide for Technosphere DPI to be used safety to treat many other diseases and disorders. https://journals.sagepub.com/doi/10.1177/15209156251412816 A Real-World Data Assessment of Pulmonary Toxicity of Inhaled Insulin for Diabetes Conclusions: While there are limitations to the interpretation of results from a study using RWD, it is reassuring that there was no increase in pulmonary toxicity attributable to inhaled TI for treatment of diabetes with respect to lung cancer, COPD, emphysema, and chronic bronchitis.
0 · Reply
grampslol
grampslol Aug. 18 at 11:23 PM
$MNKD closed pennyland as usual ...
1 · Reply
Latest News on MNKD
MannKind price target lowered to $13 from $14 at Wells Fargo

2026-08-06T10:15:53.000Z - 13 days ago

MannKind price target lowered to $13 from $14 at Wells Fargo


MannKind reports Q2 EPS (6c), consensus 2c

2026-08-05T20:37:06.000Z - 13 days ago

MannKind reports Q2 EPS (6c), consensus 2c


MannKind Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

MannKind Earnings Call Transcript: Q2 2026


MannKind Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

MannKind Earnings release: Q2 2026


MannKind Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

MannKind Quarterly report: Q2 2026


MannKind Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

MannKind Slides: Q2 2026


MannKind price target raised to $14 from $11 at Wells Fargo

2026-07-30T10:30:28.000Z - 20 days ago

MannKind price target raised to $14 from $11 at Wells Fargo


MannKind Transcript: Study result

Jul 29, 2026, 4:30 PM EDT - 20 days ago

MannKind Transcript: Study result


MannKind Press release: Study result

Jul 29, 2026, 4:30 PM EDT - 20 days ago

MannKind Press release: Study result


MannKind Slides: Study result

Jul 29, 2026, 4:30 PM EDT - 20 days ago

MannKind Slides: Study result


MannKind reports ‘positive’ Phase 1b INFLO-1 results

2026-07-29T10:45:42.000Z - 21 days ago

MannKind reports ‘positive’ Phase 1b INFLO-1 results


MannKind Transcript: FDA announcement

Jul 24, 2026, 9:00 AM EDT - 25 days ago

MannKind Transcript: FDA announcement


MannKind Press release: FDA announcement

Jul 24, 2026, 9:00 AM EDT - 25 days ago

MannKind Press release: FDA announcement


MannKind Slides: FDA announcement

Jul 24, 2026, 9:00 AM EDT - 25 days ago

MannKind Slides: FDA announcement


MannKind announces FDA approval of Furoscix ReadyFlow

2026-07-24T10:41:33.000Z - 26 days ago

MannKind announces FDA approval of Furoscix ReadyFlow


MannKind announces $50M private placement

2026-07-24T10:40:57.000Z - 26 days ago

MannKind announces $50M private placement


MannKind Announces $50 Million Private Placement

Jul 24, 2026, 6:35 AM EDT - 26 days ago

MannKind Announces $50 Million Private Placement


MannKind price target raised to $11 from $10 at Wells Fargo

2026-06-01T01:10:05.000Z - 2 months ago

MannKind price target raised to $11 from $10 at Wells Fargo


MannKind Transcript: FDA announcement

May 29, 2026, 4:30 PM EDT - 2 months ago

MannKind Transcript: FDA announcement


US FDA approves MannKind's inhaled insulin for children

May 29, 2026, 12:44 PM EDT - 2 months ago

US FDA approves MannKind's inhaled insulin for children


MannKind to Present at Jefferies Global Healthcare Conference

May 27, 2026, 4:00 PM EDT - 2 months ago

MannKind to Present at Jefferies Global Healthcare Conference


MannKind Transcript: AGM 2026

May 20, 2026, 9:00 AM EDT - 3 months ago

MannKind Transcript: AGM 2026


MannKind price target lowered to $7 from $8 at Mizuho

2026-05-07T15:49:43.000Z - 3 months ago

MannKind price target lowered to $7 from $8 at Mizuho


MannKind price target raised to $10 from $8 at H.C. Wainwright

2026-05-07T11:37:11.000Z - 3 months ago

MannKind price target raised to $10 from $8 at H.C. Wainwright


MannKind price target raised to $10 from $8 at Wells Fargo

2026-05-07T10:51:50.000Z - 3 months ago

MannKind price target raised to $10 from $8 at Wells Fargo


MannKind reports Q1 EPS (2c), consensus 1c

2026-05-07T01:17:30.000Z - 3 months ago

MannKind reports Q1 EPS (2c), consensus 1c


MannKind Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

MannKind Earnings Call Transcript: Q1 2026


MannKind Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

MannKind Earnings release: Q1 2026


MannKind Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

MannKind Quarterly report: Q1 2026


MannKind Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

MannKind Slides: Q1 2026


MannKind price target lowered to $8 from $10 at Mizuho

2026-04-13T14:45:40.000Z - 4 months ago

MannKind price target lowered to $8 from $10 at Mizuho


MannKind price target lowered to $6 from $7 at Truist

2026-04-08T12:35:39.000Z - 4 months ago

MannKind price target lowered to $6 from $7 at Truist


MannKind Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

MannKind Proxy statement: Proxy filing


MannKind Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

MannKind Proxy statement: Proxy filing


MannKind Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 3:40 PM EDT - 5 months ago

MannKind Transcript: Leerink Global Healthcare Conference 2026


MannKind Announces Settlement of Convertible Senior Notes

Mar 5, 2026, 4:30 PM EST - 5 months ago

MannKind Announces Settlement of Convertible Senior Notes


MannKind price target lowered to $8 from $10 at Wedbush

2026-03-05T14:03:29.000Z - 5 months ago

MannKind price target lowered to $8 from $10 at Wedbush

UTHR


MannKind to Participate in Upcoming Investor Conferences

Mar 4, 2026, 9:00 AM EST - 5 months ago

MannKind to Participate in Upcoming Investor Conferences


MannKind price target lowered to $7 from $8 at Wells Fargo

2026-02-27T12:57:54.000Z - 6 months ago

MannKind price target lowered to $7 from $8 at Wells Fargo


MannKind Earnings Call Transcript: Q4 2025

Feb 26, 2026, 9:00 AM EST - 6 months ago

MannKind Earnings Call Transcript: Q4 2025


MannKind Annual report: Q4 2025

Feb 26, 2026, 9:00 AM EST - 6 months ago

MannKind Annual report: Q4 2025


MannKind Earnings release: Q4 2025

Feb 26, 2026, 9:00 AM EST - 6 months ago

MannKind Earnings release: Q4 2025


MannKind Slides: Q4 2025

Feb 26, 2026, 9:00 AM EST - 6 months ago

MannKind Slides: Q4 2025


MannKind Slides: Corporate presentation

Jan 10, 2026, 7:00 AM EST - 7 months ago

MannKind Slides: Corporate presentation


MannKind Provides Business Updates and 2026 Growth Drivers

Jan 8, 2026, 8:05 AM EST - 7 months ago

MannKind Provides Business Updates and 2026 Growth Drivers


MannKind Shares FUROSCIX® Business Updates

Dec 23, 2025, 8:05 AM EST - 8 months ago

MannKind Shares FUROSCIX® Business Updates


MannKind Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 6:30 AM EST - 9 months ago

MannKind Transcript: Jefferies London Healthcare Conference 2025


MannKind to Present at the Jefferies Global Healthcare Conference

Nov 11, 2025, 4:05 PM EST - 10 months ago

MannKind to Present at the Jefferies Global Healthcare Conference


MannKind Transcript: Study Update

Nov 10, 2025, 9:00 AM EST - 10 months ago

MannKind Transcript: Study Update


MannKind Press release: Study Update

Nov 10, 2025, 9:00 AM EST - 10 months ago

MannKind Press release: Study Update


MannKind Earnings Call Transcript: Q3 2025

Nov 5, 2025, 9:00 AM EST - 10 months ago

MannKind Earnings Call Transcript: Q3 2025


MannKind Quarterly report: Q3 2025

Nov 5, 2025, 9:00 AM EST - 10 months ago

MannKind Quarterly report: Q3 2025


MannKind Earnings release: Q3 2025

Nov 5, 2025, 9:00 AM EST - 10 months ago

MannKind Earnings release: Q3 2025


MannKind Slides: Q3 2025

Nov 5, 2025, 9:00 AM EST - 10 months ago

MannKind Slides: Q3 2025


MannKind to Present at Upcoming Investor Conferences

Aug 27, 2025, 4:05 PM EDT - 1 year ago

MannKind to Present at Upcoming Investor Conferences


MannKind Transcript: M&A Announcement

Aug 25, 2025, 8:30 AM EDT - 1 year ago

MannKind Transcript: M&A Announcement


MannKind Press release: M&A Announcement

Aug 25, 2025, 8:30 AM EDT - 1 year ago

MannKind Press release: M&A Announcement


MannKind Earnings Call Transcript: Q2 2025

Aug 6, 2025, 9:00 AM EDT - 1 year ago

MannKind Earnings Call Transcript: Q2 2025


MannKind Quarterly report: Q2 2025

Aug 6, 2025, 9:00 AM EDT - 1 year ago

MannKind Quarterly report: Q2 2025


MannKind Earnings release: Q2 2025

Aug 6, 2025, 9:00 AM EDT - 1 year ago

MannKind Earnings release: Q2 2025


MannKind Slides: Corporate Presentation

Aug 6, 2025, 7:00 AM EDT - 1 year ago

MannKind Slides: Corporate Presentation


MannKind Slides: FY 2025

Jun 5, 2025, 2:35 PM EDT - 1 year ago

MannKind Slides: FY 2025


MannKind Earnings Call Transcript: Q1 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

MannKind Earnings Call Transcript: Q1 2025


MannKind Quarterly report: Q1 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

MannKind Quarterly report: Q1 2025


MannKind Earnings release: Q1 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

MannKind Earnings release: Q1 2025


MannKind Proxy statement: Proxy Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

MannKind Proxy statement: Proxy Filing


MannKind Proxy statement: Proxy Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

MannKind Proxy statement: Proxy Filing


MannKind Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MannKind Earnings Call Transcript: Q4 2024


MannKind Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MannKind Annual report: Q4 2024


MannKind Earnings release: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MannKind Earnings release: Q4 2024


MannKind Slides: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MannKind Slides: Q4 2024


Kuka
Kuka Aug. 19 at 12:46 PM
$MNKD the Algos repeat ... yesterday we had just a .06 penny swing so today I've got a limit order set for $3.96.
0 · Reply
riback9
riback9 Aug. 19 at 12:22 PM
0 · Reply
Solicurance
Solicurance Aug. 19 at 11:13 AM
$MNKD wonder when we get fast track designation for 201…
2 · Reply
clan
clan Aug. 19 at 10:40 AM
$MNKD Blockbuster potential. For the good of all Mannkind. 🇺🇲 $SPY 💪 $QQQ 🇺🇲
0 · Reply
oloccip__evets
oloccip__evets Aug. 19 at 9:29 AM
0 · Reply
ChristineMartinez757
ChristineMartinez757 Aug. 19 at 9:15 AM
$MNKD $WDC $NBIZ $USO MannKind develops inhaled and specialty medicines, Western Digital benefits from storage demand, NBIZ remains highly speculative, and USO provides crude-oil exposure. I'm watching prescription growth, data-storage cycles, funding, oil prices, and energy-market conditions.
0 · Reply
jiw392
jiw392 Aug. 19 at 9:09 AM
0 · Reply
Kuka
Kuka Aug. 19 at 3:52 AM
$MNKD just my humble opinion but I am guessing we are going to blow LQDA stock price out of the water ... this might take a year or two.
1 · Reply
kevinmik
kevinmik Aug. 19 at 2:20 AM
$MNKD Real world data showing Technophere DPI is safely used in a complex disease like diabetes opens the door wide for Technosphere DPI to be used safety to treat many other diseases and disorders. https://journals.sagepub.com/doi/10.1177/15209156251412816 A Real-World Data Assessment of Pulmonary Toxicity of Inhaled Insulin for Diabetes Conclusions: While there are limitations to the interpretation of results from a study using RWD, it is reassuring that there was no increase in pulmonary toxicity attributable to inhaled TI for treatment of diabetes with respect to lung cancer, COPD, emphysema, and chronic bronchitis.
0 · Reply
grampslol
grampslol Aug. 18 at 11:23 PM
$MNKD closed pennyland as usual ...
1 · Reply
NatesNotes
NatesNotes Aug. 18 at 10:43 PM
As we've seen many times over the years, @Ydoi , there are many on the $MNKD stream who do not understand how market makers typically handle large trades for their institutional clients... and, as you've seen on this thread, in particular, @The_Handoff_Crew (bummer of a choice of screen names, eh? Our condolences, thc ;-) ) seems to have been duped by others into thinking that there is nothing to be gleaned from such price and volume action at the end of the day (and we applaud you for calling him out on the matter ;-) ). Cheers! #thedupedest #factsmatter
1 · Reply
StockStalker4
StockStalker4 Aug. 18 at 10:02 PM
$MNKD We received some share price love from the TETON full enrollment news today. Some idiot said we moved on no news. Again idiot. More proof our device is superior!
0 · Reply
CapitalMonk
CapitalMonk Aug. 18 at 9:35 PM
$MNKD Price: $4.07 (+4.36%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.07% RSI: 55.4 | Momentum: Moderate Volume: -8.5% vs avg Volatility: 4.10% Support: $3.63 | Resistance: $4.24 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
a_failure_to_launch
a_failure_to_launch Aug. 18 at 9:27 PM
$MNKD AH shenanigans?
2 · Reply
Big_N_Long
Big_N_Long Aug. 18 at 9:09 PM
$MNKD Great closing. The smart Buyer’s are singing… Hoo-ha I am gonna tell my Ma, tell my Pa, tell everyone in Arkansas to buy MannKind. It’s about time for all us to move on up! I bought today.
0 · Reply
Bigbucksnow
Bigbucksnow Aug. 18 at 8:44 PM
$MNKD Go MNKD!
0 · Reply
a_failure_to_launch
a_failure_to_launch Aug. 18 at 8:22 PM
$MNKD Too bad Mannkind's CEO isn't speaking at this seminar. I guess it is only for winners and not whiners. Can't wait to hear what Shkreli has to say.
1 · Reply
USAEquityResearch
USAEquityResearch Aug. 18 at 8:12 PM
$MNKD 📊 USAEquityResearch ▲ 4.07 (+4.36%) Trend: Bullish 📈 RSI (14): 55.4 — neutral territory MACD: bearish, below signal line Volume: normal 📌 Key Levels Resistance: 4.13 Support: 3.73 20-MA: 3.94 | 50-MA: 3.96 Educational content only. Not financial advice.
0 · Reply
Ydoi
Ydoi Aug. 18 at 8:06 PM
$MNKD $2M shares traded in last 5 minutes. Nothing to see here!
3 · Reply
NatesNotes
NatesNotes Aug. 18 at 8:00 PM
$MNKD Big spreads in the morning and big blocks at the close? Yes, please... ;-) #iykyk
1 · Reply
bigskyliving
bigskyliving Aug. 18 at 7:59 PM
$MNKD Volume is surging and level 2 is all over the map. Something is up!
1 · Reply
RockyRambo26
RockyRambo26 Aug. 18 at 7:45 PM
$MNKD My spider senses are tingling… Watch for possible breakout this week above $4.08! Cheers!🥂
0 · Reply